Spark Therapeutics (NASDAQ:ONCE) reported Q1 2018 earnings this Morning, coming in at ($1.25) per share, missing Wall Street’s estimates of ($0.45) per Share. Revenue for the quarter came in at $15.68 million missing the streets estimates of $51.55 million Recent Insider Trading for Spark Therapeutics (NASDAQ:ONCE)
- On 4/20/2018 John Furey, COO, sold 6,723 with an average share price of $82.50 per share and the total transaction amounting to $554,647.50.
- On 4/18/2018 John Furey, COO, sold 13,277 with an average share price of $82.52 per share and the total transaction amounting to $1,095,618.04.
- On 4/12/2018 John Furey, COO, sold 20,000 with an average share price of $77.51 per share and the total transaction amounting to $1,550,200.00.
- On 12/11/2017 John Furey, COO, sold 18 with an average share price of $46.33 per share and the total transaction amounting to $833.94.
- On 12/8/2017 John Furey, COO, bought 18 with an average share price of $73.48 per share and the total transaction amounting to $1,322.64.
- On 11/28/2017 Katherine A High, Insider, sold 5,000 with an average share price of $71.32 per share and the total transaction amounting to $356,600.00.
Dividend History for Spark Therapeutics (NASDAQ:ONCE)
Recent Trading for Spark Therapeutics (NASDAQ:ONCE) Shares of Spark Therapeutics closed the previous trading session at 70.99 down -2.22 3.03% with 15510 shares trading hands.